Recall of Valsartan Blood Pressure Medication Expanded to Some Lots of Losartan Over Similar Fears of Carcinogen Tainting
As reported by CBS News, Macleods Pharmaceuticals is recalling another 32 lots of its widely used blood pressure medication Losartan that was sold nationwide, after finding the medication contained trace amounts of a probable carcinogen known as NMBA.